Opsidio
-
Radnor-Based Biotech Company Raises $800,000 in Funding
Radnor’s Opsidio, which is working on developing monoclonal antibodies for treatment of fibrotic diseases, has raised $800,000 through a debt financing deal, writes John George…
Founding Partners
Advertisement
Affiliate Partners
Chamber Partners
